SE0103313D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0103313D0
SE0103313D0 SE0103313A SE0103313A SE0103313D0 SE 0103313 D0 SE0103313 D0 SE 0103313D0 SE 0103313 A SE0103313 A SE 0103313A SE 0103313 A SE0103313 A SE 0103313A SE 0103313 D0 SE0103313 D0 SE 0103313D0
Authority
SE
Sweden
Prior art keywords
sub
sup
ring
novel compounds
phenyl
Prior art date
Application number
SE0103313A
Other languages
English (en)
Swedish (sv)
Inventor
William Brown
Christopher Walpole
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0103313A priority Critical patent/SE0103313D0/xx
Publication of SE0103313D0 publication Critical patent/SE0103313D0/xx
Priority to ARP020103670A priority patent/AR036649A1/es
Priority to PCT/SE2002/001804 priority patent/WO2003029215A1/en
Priority to HU0401915A priority patent/HUP0401915A2/hu
Priority to CNA028195825A priority patent/CN1692100A/zh
Priority to IL16088902A priority patent/IL160889A0/xx
Priority to BR0212959-0A priority patent/BR0212959A/pt
Priority to KR10-2004-7004780A priority patent/KR20040039469A/ko
Priority to RU2004107854/04A priority patent/RU2004107854A/ru
Priority to MXPA04003056A priority patent/MXPA04003056A/es
Priority to CA002460168A priority patent/CA2460168A1/en
Priority to EP02775640A priority patent/EP1440060A1/en
Priority to US10/491,263 priority patent/US7205317B2/en
Priority to JP2003532465A priority patent/JP2005505583A/ja
Priority to PL02368804A priority patent/PL368804A1/xx
Priority to ZA200402514A priority patent/ZA200402514B/xx
Priority to IS7203A priority patent/IS7203A/is
Priority to CO04030712A priority patent/CO5580822A2/es
Priority to NO20041964A priority patent/NO20041964L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE0103313A 2001-10-03 2001-10-03 Novel compounds SE0103313D0 (sv)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SE0103313A SE0103313D0 (sv) 2001-10-03 2001-10-03 Novel compounds
ARP020103670A AR036649A1 (es) 2001-10-03 2002-09-27 Derivados de diarilmetilen piperidina, uso de estos derivados para la manufactura de medicamentos y composicion farmaceutica
PL02368804A PL368804A1 (en) 2001-10-03 2002-10-02 4(piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders
RU2004107854/04A RU2004107854A (ru) 2001-10-03 2002-10-02 Производные 4[пиперидин-4-илиден-(3-карбомоилфенил)метил]бензамида и их применение для лечении боли, спинальных повреждений или желудочно-кишечных расстройств
EP02775640A EP1440060A1 (en) 2001-10-03 2002-10-02 4(piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders
CNA028195825A CN1692100A (zh) 2001-10-03 2002-10-02 4-[哌啶-4-亚基-(3-氨基甲酰苯基)甲基]苯甲酰胺衍生物及其在治疗疼痛、脊椎损伤或胃肠疾病方面的应用
IL16088902A IL160889A0 (en) 2001-10-03 2002-10-02 4 [piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders
BR0212959-0A BR0212959A (pt) 2001-10-03 2002-10-02 Composto, uso do mesmo, composição farmacêutica, e, métodos para o tratamento da dor, de distúrbios gastrointestinais e de lesões espinhais
KR10-2004-7004780A KR20040039469A (ko) 2001-10-03 2002-10-02 4[피페리딘-4-일리덴-(3-카르바모일페닐)메틸]벤즈아미드유도체 및 통증, 척추 손상 또는 위장 장애 치료에있어서의 이들의 용도
PCT/SE2002/001804 WO2003029215A1 (en) 2001-10-03 2002-10-02 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders
MXPA04003056A MXPA04003056A (es) 2001-10-03 2002-10-02 Derivados de 4?piperidin-4-iliden-(3-carbamoilfenil)metil? benzamida y su uso para tratamiento de dolor, lesiones espinales o transtornos gastrointestinales.
CA002460168A CA2460168A1 (en) 2001-10-03 2002-10-02 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders
HU0401915A HUP0401915A2 (hu) 2001-10-03 2002-10-02 4-[4-Piperidinilidén-(3-karbamoil-fenil)-metil]-benzamid-származékok és alkalmazásuk fájdalom, gerincsérülések vagy gasztrointesztinális rendellenességek kezelésére és ezeket tartalmazó gyógyszerkészítmények
US10/491,263 US7205317B2 (en) 2001-10-03 2002-10-02 4[piperidin-4-yliden-(3-carbamoylpheny)methyl]benzamide derivatives and their use for the treatment of pain spinal injuries or gastrointestinal disorders
JP2003532465A JP2005505583A (ja) 2001-10-03 2002-10-02 4[ピペリジン−4−イリデン−(3−カルバモイルフェニル)メチル]ベンズアミド誘導体、および疼痛、脊髄損傷または胃腸疾患の治療のためのその使用
ZA200402514A ZA200402514B (en) 2001-10-03 2004-03-30 4[Piperidin-4-yliden-(3-carbamoylphenyl)methyl]benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders.
IS7203A IS7203A (is) 2001-10-03 2004-03-31 4[píperidín-4-ýliden-(3-karbamólýlfenýl)metýl]bensamíðafleiður og notkun þeirra til að meðhöndla verki, mænuskaða eða maga- og garnasjúkdóma
CO04030712A CO5580822A2 (es) 2001-10-03 2004-03-31 Derivados de 4[piperidin-4-iliden-(3-carbamoilfenil)metil] benzamida y sus usos para el tratamiento del dolor, las lesiones en la columna vertebral o desordenes gastrointes- tinales
NO20041964A NO20041964L (no) 2001-10-03 2004-04-27 4-[Piperidin-4-yliden-(3-karbamoylfenyl)metyl]benzamidderivater og deres anvendelse ved behandling av smerte, spinalskader og gastrointestinale forstyrrelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0103313A SE0103313D0 (sv) 2001-10-03 2001-10-03 Novel compounds

Publications (1)

Publication Number Publication Date
SE0103313D0 true SE0103313D0 (sv) 2001-10-03

Family

ID=20285553

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0103313A SE0103313D0 (sv) 2001-10-03 2001-10-03 Novel compounds

Country Status (19)

Country Link
US (1) US7205317B2 (xx)
EP (1) EP1440060A1 (xx)
JP (1) JP2005505583A (xx)
KR (1) KR20040039469A (xx)
CN (1) CN1692100A (xx)
AR (1) AR036649A1 (xx)
BR (1) BR0212959A (xx)
CA (1) CA2460168A1 (xx)
CO (1) CO5580822A2 (xx)
HU (1) HUP0401915A2 (xx)
IL (1) IL160889A0 (xx)
IS (1) IS7203A (xx)
MX (1) MXPA04003056A (xx)
NO (1) NO20041964L (xx)
PL (1) PL368804A1 (xx)
RU (1) RU2004107854A (xx)
SE (1) SE0103313D0 (xx)
WO (1) WO2003029215A1 (xx)
ZA (1) ZA200402514B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002305994B2 (en) 2001-05-18 2008-06-26 Astrazeneca Ab 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
EP2198976A3 (en) 2002-11-07 2014-08-20 Abbott Laboratories Method of loading beneficial agent to a prosthesis by fluid-jet application
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0301442D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations therof and uses thereof
JP2007503457A (ja) * 2003-05-16 2007-02-22 アストラゼネカ・アクチエボラーグ ジアリールメチリデンピペリジン誘導体、その製造およびその使用
SE0301445D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
WO2005003131A1 (en) * 2003-06-27 2005-01-13 Janssen Pharmaceutica N.V. Tricyclic delta opioid modulators
CA2541014A1 (en) 2003-10-01 2005-04-14 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
EP2301619B1 (en) 2004-03-19 2017-05-10 Abbott Laboratories Multiple drug delivery from a balloon and a prosthesis
US20100030183A1 (en) 2004-03-19 2010-02-04 Toner John L Method of treating vascular disease at a bifurcated vessel using a coated balloon
KR101234421B1 (ko) 2004-08-02 2013-02-18 아스트라제네카 아베 디아릴메틸 피페라진 유도체, 이의 제조 방법 및 용도
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
AU2007294968A1 (en) 2006-09-12 2008-03-20 Adolor Corporation Use of N-containing spirocompounds for the enhancement of cognitive function
EP3233825B1 (en) 2014-12-19 2020-04-29 Pharmnovo AB Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
WO2016099394A1 (en) * 2014-12-19 2016-06-23 Pharmnovo Ab Novel selective delta-opioid receptor agonists useful for the treatment of pain, anxiety and depression.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2898339A (en) * 1957-07-29 1959-08-04 Wm S Merrell Co N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine
US4581171A (en) * 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US5140029A (en) * 1989-01-09 1992-08-18 Janssen Pharmaceutica N.V. 2-aminopyrimidinone derivatives
US4939137A (en) * 1989-06-28 1990-07-03 Ortho Pharmaceutical Corporation Ring-fused thienopyrimidinedione derivatives
US5683998A (en) * 1991-04-23 1997-11-04 Toray Industries, Inc. Tricyclic triazolo derivatives, processes for producing the same and the uses of the same
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
DK1049676T3 (da) 1997-12-24 2006-01-16 Ortho Mcneil Pharm Inc 4-[Aryl(piperidin-4-yl)]aminobenzamider, som binder til delta-opioidreceptoren
SE0001207D0 (sv) * 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
SE0001208D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds

Also Published As

Publication number Publication date
HUP0401915A2 (hu) 2005-01-28
CO5580822A2 (es) 2005-11-30
IL160889A0 (en) 2004-08-31
US20050020629A1 (en) 2005-01-27
WO2003029215A1 (en) 2003-04-10
JP2005505583A (ja) 2005-02-24
US7205317B2 (en) 2007-04-17
CA2460168A1 (en) 2003-04-10
NO20041964L (no) 2004-04-27
BR0212959A (pt) 2004-10-13
KR20040039469A (ko) 2004-05-10
RU2004107854A (ru) 2005-09-10
MXPA04003056A (es) 2004-07-05
PL368804A1 (en) 2005-04-04
ZA200402514B (en) 2005-01-24
IS7203A (is) 2004-03-31
AR036649A1 (es) 2004-09-22
CN1692100A (zh) 2005-11-02
EP1440060A1 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
SE0001207D0 (sv) Novel compounds
SE0103313D0 (sv) Novel compounds
MXPA03010445A (es) Derivados de 4(fenil-piperazinil-metil) benzamida y su uso para tratamiento del dolor, ansiedad o trastornos gastrointestinales.
SE0101765D0 (sv) Novel compounds
SE0001208D0 (sv) Novel compounds
SE0101766D0 (sv) Novel compounds
IS6423A (is) Ný efnasambönd
SE0001209D0 (sv) Novel compounds
BG106807A (en) Novel compounds
SE0101768D0 (sv) Novel compounds
SE0101771D0 (sv) Novel compounds
SE0101767D0 (sv) Novel compounds
SE0101769D0 (sv) Novel compounds
SE0101770D0 (sv) Novel compounds
SE0104326D0 (sv) Therapeutic heterocycles
SE0101773D0 (sv) Novel compounds
SE0101772D0 (sv) Novel compounds
AR027040A1 (es) Compuestos novedosos